- Home
- MAA vs MRNA Comparison
MAA vs MRNA Comparison
Compare MAA & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAA
- MRNA
- Stock Information
- Founded
- MAA 1977
- MRNA 2010
- Country
- MAA United States
- MRNA United States
- Employees
- MAA N/A
- MRNA N/A
- Industry
- MAA Real Estate Investment Trusts
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAA Real Estate
- MRNA Health Care
- Exchange
- MAA Nasdaq
- MRNA Nasdaq
- Market Cap
- MAA 18.2B
- MRNA 16.0B
- IPO Year
- MAA 1994
- MRNA 2018
- Fundamental
- Price
- MAA $160.70
- MRNA $35.53
- Analyst Decision
- MAA Buy
- MRNA Hold
- Analyst Count
- MAA 20
- MRNA 20
- Target Price
- MAA $171.40
- MRNA $59.65
- AVG Volume (30 Days)
- MAA 793.2K
- MRNA 13.6M
- Earning Date
- MAA 02-05-2025
- MRNA 02-14-2025
- Dividend Yield
- MAA 3.79%
- MRNA N/A
- EPS Growth
- MAA N/A
- MRNA N/A
- EPS
- MAA 4.49
- MRNA N/A
- Revenue
- MAA $2,191,015,000.00
- MRNA $3,236,000,000.00
- Revenue This Year
- MAA N/A
- MRNA N/A
- Revenue Next Year
- MAA $4.07
- MRNA $22.19
- P/E Ratio
- MAA $35.69
- MRNA N/A
- Revenue Growth
- MAA 1.98
- MRNA N/A
- 52 Week Low
- MAA $123.23
- MRNA $29.25
- 52 Week High
- MAA $167.39
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- MAA 65.54
- MRNA 48.60
- Support Level
- MAA $156.39
- MRNA $32.78
- Resistance Level
- MAA $158.93
- MRNA $36.98
- Average True Range (ATR)
- MAA 2.83
- MRNA 2.50
- MACD
- MAA 0.57
- MRNA 0.30
- Stochastic Oscillator
- MAA 95.26
- MRNA 66.81
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.